The Effects of Palatal Pre-sutures in Connective Tıssue Graft Surgery
1 other identifier
interventional
32
1 country
1
Brief Summary
Connective tissue graft operation is one of the most frequently performed surgical procedures to increase the width of the attached gingiva and to treat gingival recessions. The most preferred donor site during this operation is the palatal mucosa.Reported postoperative complications are usually related to the donor site. Problems such as prolongation of bleeding time, delay in wound healing and severe pain in the palatal region where the graft is taken are frequently encountered. Bleeding control in the palatal donor area is very important for patient comfort. Additional measures may be required to control bleeding, such as sutures with or without hemostatic agents, or acrylic, plastic palatal stents and periodontal pastes prepared before the operation. Suturing the Greater Palatine Artery (GPA) or terminal vessel branches has been shown to be an effective method to control palatal bleeding. Therefore the aim of this study is to evaluate the effectiveness of the pre-suture method applied in the palatal region before the connective tissue graft is taken in reducing hemostasis.Pre-suture method can increase the operator's field of vision and operational comfort. Patient-reported outcomes such as the amount of pain and bleeding in the palatal donor area during and after surgery, painkiller intake, number of days of discomfort, satisfaction, quality of life, and willingness to be treated will be evaluated. In addition, it will be evaluated whether this suture technique affects the healing of the half-thickness flap in the palatal region after obtaining a connective tissue graft with a single incision method.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 3, 2022
CompletedFirst Posted
Study publicly available on registry
May 27, 2022
CompletedStudy Start
First participant enrolled
January 9, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 29, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 29, 2024
CompletedJanuary 7, 2026
January 1, 2026
1.3 years
April 3, 2022
January 6, 2026
Conditions
Outcome Measures
Primary Outcomes (11)
Measuring the Amount of Intra-operative Bleeding with a Precision Balance
In our study, the amount of blood lost will be estimated by using the gauze weight method, which is a method of directly estimating blood loss. All measurements will be made on a 1 g precision digital balance. Sterile gauze swabs will be weighed dry before the operation. The gauze pads that will be used later will be moistened with 10 mL of sterile 0.9 g/L saline solution before starting the procedure and the weight will be measured again. The time from the removal of the connective tissue graft to the end of the operation will be measured and the pre-moistened gauze pads will be used on the palate during this period and will be stored separately and their weight will be measured immediately after the operation is over. In this method, aspiration in the palatal region should be avoided to minimize errors in blood loss measurement.
During surgery
Reporting of secondary bleeding as present/absent in the 1st postoperative week
Reporting of secondary bleeding as present/absent both by the patient and by the physician in the follow-up appointments in the 1st postoperative weeks
1st postoperative week after the operation.
patient discomfort and satisfaction [Oral Health Impact Profile ]
In this evaluation, the Oral Health Impact Profile (OHIP-14) test will be used by marking the patients on the 3rd postoperative day. Likert response system in the evaluation of the OHIP14 scale: 0: "never", 1. "very little" 2. "sometimes" 3. "quite often" 4. is rated as "often". The total score of the answers given by the participant to each item is evaluated by calculating. The total score is minimum 0, maximum 56. It is concluded that as the total score increases, the severity of the problem increases and the quality of life decreases.
On the 3rd day after the operation.
Evaluation of the pain felt by the patients after the operation with Visual Analogue Scale
Pain scores will be recorded on the postoperative 3rd day. It is determined by the patient's assessment of the intensity of pain felt on a scale from 0 to 10. 0: No pain, 10: There is unbearable pain.
3rd day after the operation.
Reporting of secondary bleeding as present/absent in the 2nd postoperative week
Reporting of secondary bleeding as present/absent both by the patient and by the physician in the follow-up appointments in the 2nd postoperative weeks
2nd postoperative week after the operation.
patient discomfort and satisfaction [Oral Health Impact Profile ]
In this evaluation, the Oral Health Impact Profile (OHIP-14) test will be used by marking the patients on the 1st postoperative week. Likert response system in the evaluation of the OHIP14 scale: 0: "never", 1. "very little" 2. "sometimes" 3. "quite often" 4. is rated as "often". The total score of the answers given by the participant to each item is evaluated by calculating. The total score is minimum 0, maximum 56. It is concluded that as the total score increases, the severity of the problem increases and the quality of life decreases.
1st week after the operation.
patient discomfort and satisfaction [Oral Health Impact Profile ]
In this evaluation, the Oral Health Impact Profile (OHIP-14) test will be used by marking the patients on the 2nd postoperative week. Likert response system in the evaluation of the OHIP14 scale: 0: "never", 1. "very little" 2. "sometimes" 3. "quite often" 4. is rated as "often". The total score of the answers given by the participant to each item is evaluated by calculating. The total score is minimum 0, maximum 56. It is concluded that as the total score increases, the severity of the problem increases and the quality of life decreases.
2nd week after the operation.
patient discomfort and satisfaction [Oral Health Impact Profile ]
In this evaluation, the Oral Health Impact Profile (OHIP-14) test will be used by marking the patients on the 4th postoperative week. Likert response system in the evaluation of the OHIP14 scale: 0: "never", 1. "very little" 2. "sometimes" 3. "quite often" 4. is rated as "often". The total score of the answers given by the participant to each item is evaluated by calculating. The total score is minimum 0, maximum 56. It is concluded that as the total score increases, the severity of the problem increases and the quality of life decreases.
4th week after the operation.
Evaluation of the pain felt by the patients after the operation with Visual Analogue Scale
Pain scores will be recorded on the postoperative 1st week by marking the Visual Analogue Scale (VAS). It will be determined on a scale from 0 (no pain) to 10 (unbearable pain). It is determined by the patient's assessment of the intensity of pain felt on a scale from 0 to 10. 0: No pain 10: There is unbearable pain
1st week after the operation.
Evaluation of the pain felt by the patients after the operation with Visual Analogue Scale.
Pain scores will be recorded on the postoperative 2nd week by marking the Visual Analogue Scale (VAS). It will be determined on a scale from 0 (no pain) to 10 (unbearable pain). It is determined by the patient's assessment of the intensity of pain felt on a scale from 0 to 10. 0: No pain, 10: There is unbearable pain.
2nd week after the operation.
Evaluation of the pain felt by the patients after the operation with Visual Analogue Scale
Pain scores will be recorded on the postoperative 4th week by marking the Visual Analogue Scale (VAS). It will be determined on a scale from 0 (no pain) to 10 (unbearable pain). It is determined by the patient's assessment of the intensity of pain felt on a scale from 0 to 10. 0: No pain, 10: There is unbearable pain.
4th week after the operation.
Secondary Outcomes (8)
Evaluation of palatal wound healing by measuring the Early Wound Healing Index in the first 3 months after the operation
3rd day after surgery.
Findings of necrosis on the donor area
During and first 3 months after surgery
Findings of healing with complications on the donor area
During and first 3 months after surgery
Evaluation of palatal wound healing by measuring the Early Wound Healing Index
1st week after surgery.
Evaluation of palatal wound healing by measuring the Early Wound Healing Index
2nd week after surgery.
- +3 more secondary outcomes
Study Arms (2)
Palatal Pre-Suture (GPCS)
EXPERIMENTALIn the test group, GPCS (Silk, 4-0, 18 mm, 3/8 sharp needle) will be placed before the incision in the palatal region. GPCS will be taken one week after surgery.
No Palatal Suture (No GPCS) - Control
ACTIVE COMPARATORIn the control group, no sutures will be applied before graft harvesting from the palate.
Interventions
The pressure application will be applied before the incision on the palate.
A graft will be taken from the palate before the procedure is applied.
Eligibility Criteria
You may qualify if:
- \- The patient must be over the age of 18,
- Not having any systemic disease,
- Not receiving chemotherapy or radiotherapy treatment,
- Not using drugs regularly and not being addicted to drugs,
- Not be in pregnancy and/or lactation period,
- Not smoking,
- Not having received antibiotic treatment in the last 6 months,
- Presence of Cairo Type 1 or Type 2 recession defect in a single tooth,
- The patient is cooperative.
You may not qualify if:
- The patient is younger than 18 years old,
- Active infectious disease (acute hepatitis, AIDS, tuberculosis), cancer or any systemic condition that may affect periodontal tissues,
- Receiving chemotherapy or radiotherapy treatment,
- Being on regular medication and being addicted to drugs,
- Patients with a plaque score greater than 20% after phase I treatment (Silness and Löe, 1964),
- Being in pregnancy and/or lactation period,
- Being a smoker
- To have been treated with antibiotics in the last 6 months,
- Not being cooperative.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Biruni University
Istanbul, Zeytinburnu, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Burcu Karaduman
bkaraduman@biruni.edu.tr
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 3, 2022
First Posted
May 27, 2022
Study Start
January 9, 2023
Primary Completion
April 29, 2024
Study Completion
July 29, 2024
Last Updated
January 7, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share